Saptarshi Chakraborty

Saptarshi Chakraborty

Auto-generated profile, based on publicly available information

Saptarshi Chakraborty

Department of Biostatistics State University of New York at Buffalo Buffalo New York USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in Agriculture, Ecosystems & Environment
Verified
Journal Article
Closed access
NCNilovna Chatterjee
Nilovna Chatterjee
PNP.K.Ramachandran. Nair
P.K.Ramachandran. Nair
SCSaptarshi Chakraborty
Saptarshi Chakraborty
VNVimala D. Nair
Vimala D. Nair

14 April 2020 in Neurology
Verified
Journal Article
Closed access
PDF file
WRWilliam D. Rooney
William D. Rooney
YBYosef A. Berlow
Yosef A. Berlow
WTWilliam T. Triplett
William T. Triplett
SFSean C. Forbes
Sean C. Forbes
RWRebecca J. Willcocks
Rebecca J. Willcocks
KVKrista Vandenborne
Krista Vandenborne
Objective To quantify disease progression in individuals with Duchenne muscular dystrophy (DMD) using magnetic resonance biomarkers of leg muscles. Methods MRI and magnetic resonance spectroscopy (MRS) biomarkers were acquired from 104 participants with DMD and 51 healthy controls using a prospective observational study design with patients with DMD followed up yearly for up to 6 years. Fat fractions (FFs) in vastus lateralis and soleus muscles were determined with 1H MRS. MRI quantitative T2 (qT2) values were measured for 3 muscles of the upper leg and 5 muscles of the lower leg. Longitudinal changes in biomarkers were modeled with a cumulative distribution function using a nonlinear mixed-effects approach. Results MRS FF and MRI qT2 increased with DMD disease duration, with the progression time constants differing markedly between individuals and across muscles. The average age at half-maximal muscle involvement (μ) occurred 4.8 years earlier in vastus lateralis than soleus, and these measures were strongly associated with loss-of-ambulation age. Corticosteroid treatment was found to delay μ by 2.5 years on average across muscles, although there were marked differences between muscles with more slowly progressing muscles showing larger delay. Conclusions MRS FF and MRI qT2 provide sensitive noninvasive measures of DMD progression. Modeling changes in these biomarkers across multiple muscles can be used to detect and monitor the therapeutic effects of corticosteroids on disease progression and to provide prognostic information on functional outcomes. This modeling approach provides a method to transform these MRI biomarkers into well-understood metrics, allowing concise summaries of DMD disease progression at individual and population levels. ClinicalTrials.gov identifier: NCT01484678.

1 January 2017 in Electronic Journal of Statistics
Verified
Journal Article
Open access
PDF file
SCSaptarshi Chakraborty
Saptarshi Chakraborty
KKKshitij Khare
Kshitij Khare
The Bayesian probit regression model (Albert and Chib [1]) is popular and widely used for binary regression. While the improper flat prior for the regression coefficients is an appropriate choice in the absence of any prior information, a proper normal prior is desirable when prior information is available or in modern high dimensional settings where the number of coefficients ($p$) is greater than the sample size ($n$). For both choices of priors, the resulting posterior density is intractable and a Data Augmentation (DA) Markov chain is used to generate approximate samples from the posterior distribution. Establishing geometric ergodicity for this DA Markov chain is important as it provides theoretical guarantees for constructing standard errors for Markov chain based estimates of posterior quantities. In this paper, we first show that in case of proper normal priors, the DA Markov chain is geometrically ergodic for all choices of the design matrix $X$, $n$ and $p$ (unlike the improper prior case, where $n\geq p$ and another condition on $X$ are required for posterior propriety itself). We also derive sufficient conditions under which the DA Markov chain is trace-class, i.e., the eigenvalues of the corresponding operator are summable. In particular, this allows us to conclude that the Haar PX-DA sandwich algorithm (obtained by inserting an inexpensive extra step in between the two steps of the DA algorithm) is strictly better than the DA algorithm in an appropriate sense.

8 October 2021 in JCI Insight
Verified
Journal Article
Open access
PDF file
Chelsie ArmbrusterChelsie Armbruster
Chelsie Armbruster
ABAimee L. Brauer
Aimee L. Brauer
MHMonica S. Humby
Monica S. Humby
JSJiahui Shao
Jiahui Shao
SCSaptarshi Chakraborty
Saptarshi Chakraborty
BACKGROUND: Catheterization facilitates continuous bacteriuria, for which the clinical significance remains unclear. This study aimed to determine the clinical presentation, epidemiology, and dynamics of bacteriuria in a cohort of long-term catheterized nursing home residents. METHODS: Prospective urine culture, urinalysis, chart review, and assessment of signs and symptoms of infection were performed weekly for 19 study participants over 7 months. All bacteria ≥ 1 × 10 3 cfu/mL were cultured, isolated, identified, and tested for susceptibility to select antimicrobials. RESULTS: In total, 226 of the 234 urine samples were polymicrobial (97%), with an average of 4.7 isolates per weekly specimen. A total of 228 urine samples (97%) exhibited ≥ 1 × 10 6 CFU/mL, 220 (94%) exhibited abnormal urinalysis, 126 (54%) were associated with at least 1 possible sign or symptom of infection, and 82 (35%) would potentially meet a standardized definition of catheter-associated urinary tract infection (CAUTI), but only 3 had a caregiver diagnosis of CAUTI. Bacterial isolates (286; 30%) were resistant to a tested antimicrobial agent, and bacteriuria composition was remarkably stable despite a combined total of 54 catheter changes and 23 weeks of antimicrobial use. CONCLUSION: Bacteriuria composition was largely polymicrobial, including persistent colonization by organisms previously considered to be urine culture contaminants. Neither antimicrobial use nor catheter changes sterilized the urine, at most resulting in transient reductions in bacterial burden followed by new acquisition of resistant isolates. Thus, this patient population exhibits a high prevalence of bacteriuria coupled with potential indicators of infection, necessitating further exploration to identify sensitive markers of true infection. FUNDING: This work was supported by the NIH (R00 DK105205, R01 DK123158, UL1 TR001412).

1 March 2018 in Journal of Neurosurgery
Verified
Journal Article
Closed access
SVSasha Vaziri
Sasha Vaziri
JWJacob Wilson
Jacob Wilson
JAJoseph Abbatematteo
Joseph Abbatematteo
PKPaul Kubilis
Paul Kubilis
SCSaptarshi Chakraborty
Saptarshi Chakraborty
DHDaniel J. Hoh
Daniel J. Hoh
OBJECTIVE: The American College of Surgeons (ACS) National Surgical Quality Improvement Program (NSQIP) universal Surgical Risk Calculator is an online decision-support tool that uses patient characteristics to estimate the risk of adverse postoperative events. Further validation of this risk calculator in the neurosurgical population is needed; therefore, the object of this study was to assess the predictive performance of the ACS NSQIP Surgical Risk Calculator in neurosurgical patients treated at a tertiary care center.METHODS: A single-center retrospective review of 1006 neurosurgical patients treated in the period from September 2011 through December 2014 was performed. Individual patient characteristics were entered into the NSQIP calculator. Predicted complications were compared with actual occurrences identified through chart review and administrative quality coding data. Statistical models were used to assess the predictive performance of risk scores. Traditionally, an ideal risk prediction model demonstrates good calibration and strong discrimination when comparing predicted and observed events.RESULTS: The ACS NSQIP risk calculator demonstrated good calibration between predicted and observed risks of death (p = 0.102), surgical site infection (SSI; p = 0.099), and venous thromboembolism (VTE; p = 0.164) Alternatively, the risk calculator demonstrated a statistically significant lack of calibration between predicted and observed risk of pneumonia (p = 0.044), urinary tract infection (UTI; p < 0.001), return to the operating room (p < 0.001), and discharge to a rehabilitation or nursing facility (p < 0.001). The discriminative performance of the risk calculator was assessed using the c-statistic. Death (c-statistic 0.93), UTI (0.846), and pneumonia (0.862) demonstrated strong discriminative performance. Discharge to a rehabilitation facility or nursing home (c-statistic 0.794) and VTE (0.767) showed adequate discrimination. Return to the operating room (c-statistic 0.452) and SSI (0.556) demonstrated poor discriminative performance. The risk prediction model was both well calibrated and discriminative only for 30-day mortality.CONCLUSIONS: This study illustrates the importance of validating universal risk calculators in specialty-specific surgical populations. The ACS NSQIP Surgical Risk Calculator could be used as a decision-support tool for neurosurgical informed consent with respect to predicted mortality but was poorly predictive of other potential adverse events and clinical outcomes.

3 December 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
SCSaptarshi Chakraborty
Saptarshi Chakraborty
AAArshi Arora
Arshi Arora
CBColin B. Begg
Colin B. Begg
RSRonglai Shen
Ronglai Shen
To date, the vast preponderance of somatic variants observed in the cancer genome have been rare variants, and it is common in practice to encounter in a new tumor variants that have not been observed previously. Here we focus on probability estimation for encountering such hitherto unseen variants. We draw upon statistical methodology that has been developed in other fields of study, notably in species estimation in ecology, and word frequency estimation in computational linguistics. Analysis of whole-exome and targeted panel sequencing data sets reveal substantial variability in variant “richness” between genes that could be harnessed for clinically relevant problems. We quantify the variant-tissue association and show a strong gene-specific, lineage-dependent pattern of encountering new variants. This variability is largely determined by the proportion of observed variants that are rare. Our findings suggest that variants that occur at very low frequencies can harbor important signals that are clinically consequential.